Header

UZH-Logo

Maintenance Infos

Einfluss der medikamentösen Cholesterinsenkung auf den Ressourcenverbrauch im Gesundheitswesen - Bedeutung der Scandinavian Simvastatin Survival Study (4-S-Studie) für die Kostenreduktion unter Schweizer Verhältnissen


Szucs, Thomas D; Lüscher, T F; Gutzwiller, Felix (1997). Einfluss der medikamentösen Cholesterinsenkung auf den Ressourcenverbrauch im Gesundheitswesen - Bedeutung der Scandinavian Simvastatin Survival Study (4-S-Studie) für die Kostenreduktion unter Schweizer Verhältnissen. Swiss Medical Weekly, 127(44):1819-1823.

Abstract

Upward spiralling health care expenditures have triggered the need to assess the cost-effectiveness of medical interventions. Specifically, interventions in primary and secondary prevention represent an important field of research. A resource utilization analysis was performed on the basis of the recently published Scandinavian Simvastatin Survival Study. It could be shown that treatment with simvastatin compared to placebo leads to a reduction in patient costs of CHF 8.4 million. This represents a reduction of CHF 3770.- per patient. The effective daily treatment costs can thus be calculated at CHF 1.11, which is equivalent to 36% of the actual acquisition cost per day. These results support the notion that secondary coronary prevention is not only justified from a clinical but also from an economic point of view.

Abstract

Upward spiralling health care expenditures have triggered the need to assess the cost-effectiveness of medical interventions. Specifically, interventions in primary and secondary prevention represent an important field of research. A resource utilization analysis was performed on the basis of the recently published Scandinavian Simvastatin Survival Study. It could be shown that treatment with simvastatin compared to placebo leads to a reduction in patient costs of CHF 8.4 million. This represents a reduction of CHF 3770.- per patient. The effective daily treatment costs can thus be calculated at CHF 1.11, which is equivalent to 36% of the actual acquisition cost per day. These results support the notion that secondary coronary prevention is not only justified from a clinical but also from an economic point of view.

Statistics

Citations

6 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Other titles:Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions
Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dewey Decimal Classification:610 Medicine & health
Language:German
Date:1997
Deposited On:27 May 2014 14:47
Last Modified:08 Dec 2017 05:50
Publisher:EMH Swiss Medical Publishers
ISSN:0036-7672
PubMed ID:9446200

Download

Full text not available from this repository.